Levoxyl

   
Google
 
Web NewDrugInformation.com

Levoxyl


Drug - Levoxyl
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Levothyroxine Sodium
Multiple ingredients are in alphabetical order.

Strength - 0.112MG **See Current Cumulative Supplement 1.3
The potency of the active ingredient(s), Levothyroxine Sodium. May repeat for multiple part products.

Applicant - JONES PHARMA
The firm name holding legal responsibility for Levoxyl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021301
The FDA assigned number to Levoxyl. Format is nnnnnn.

Product Number - 006
The FDA assigned number to identify Levoxyl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB1,AB3
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 25, 2001
The date Levoxyl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Levoxyl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Levoxyl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Jones Pharma Inc Sub King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Levoxyl.

Levoxyl